<p>Titanium and its alloys, while standard for biomedical implants, lack inherent antibacterial properties, posing significant infection risks. Alloying with Ag is a known antibacterial strategy, but previous methods have been limited to laboratory-scale production and often suffer from Ag segregation and the formation of brittle intermetallics, which compromise mechanical property. This study demonstrates the successful industrial-scale production of a compositionally homogeneous Ti-0.9&#xa0;wt.%Ag alloy strip (0.5&#xa0;mm × 380&#xa0;mm × 1300&#xa0;m) via vacuum arc remelting (VAR) and subsequent plastic forming. Microstructural analysis confirmed the complete and uniform dissolution of Ag into the α-Ti matrix as a solid solution, successfully preventing the formation of detrimental intermetallics like Ti₂Ag. Consequently, the Ti-Ag alloy strip exhibits exceptional broad-spectrum antibacterial efficacy, with rates exceeding 99% against three clinically prevalent bacteria (Escherichia coli, Staphylococcus aureus, and Salmonella enterica subsp. enterica serovar Typhimurium). This potent activity is attributed to the sustained release of Ag⁺ ions from the homogeneous solid solution structure. Critically, this antibacterial property is coupled with superior mechanical performance. The alloy demonstrates an increase in tensile strength of 337&#xa0;MPa over TA1 (303&#xa0;MPa) while retaining excellent ductility (46% compared to 49% for TA1). The combination of scalable manufacturing, potent antibacterial activity, and robust mechanical performance positions this low-Ag-content alloy as a highly promising material for next-generation infection-resistant biomedical implants.</p>